NIKA PHARMACEUTICALS, INC (NIKA): M&A transaction — Nika cancels May 2024 acquisition of Nika Pharmaceuticals Ltd; auditor resigns

NIKA PHARMACEUTICALS, INC

On Aug 18, 2024, board cancelled the acquisition of Nika Pharmaceuticals, Ltd. effective May 9, 2024; subsidiary returned to Savov on Aug 23.
Nika no longer owns Nika Europe, Ltd. nor the factory/land assets acquired in May 2024.
Independent auditor Fruci & Associates II, PLLC resigned on Aug 21, 2024; company seeking new auditor.
Company states it will try to publish its 10-Q as early as possible.

item 2.01 item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.7

NIKA PHARMACEUTICALS, INC completed a disposition involving Dimitar Slavchev Savov (closed 2024-08-23).

Action: disposition
Counterparty: Dimitar Slavchev Savov
Closing: 2024-08-23

Exact text from the filing

The procedure to return the 100% to Dimitar Slavchev Savov, who is an officer and director of Nika Pharmaceluticals, Inc. and general manager of Nika Pharmaceuticals, Ltd., was initiated on August 19, 2024 and was made effective on August 23, 2024, resulting in Nika Pharmaceuticals, Ltd. no longer being a wholly owned subsidiary of Nika Pharmaceuticals, Inc.

View on SEC.gov

Browse all m&a transactions →

NIKA PHARMACEUTICALS, INC filing history →

Source: SEC EDGAR

accession 0001826466-24-000096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.